XML 35 R22.htm IDEA: XBRL DOCUMENT v3.21.1
Share-based Compensation (Tables)
9 Months Ended
Mar. 31, 2021
Share-Based Compensation Expense for Stock Awards
Total share-based compensation expense for all stock awards consists of the following (in thousands):
 
   
Three Months Ended
March 31,
  
Nine Months Ended
March 31,
   
2021
  
2020
  
2021
  
2020
Research and development
   $1,207   $696   $3,496   $2,220
General and administrative
    1,438    854    4,700    3,214
   
 
 
    
 
 
    
 
 
    
 
 
 
Total share-based compensation
   $2,645   $1,550   $8,196   $5,434
   
 
 
    
 
 
    
 
 
    
 
 
 
Summary of Stock Option Activity and Related Data
Stock option activity for the nine months ended March 31, 2021 was as follows:
 
   
Number of
Options
 
Weighted-
Average
Exercise Price
  
Weighted-Average

Remaining Contractual
Term (in years)
  
Aggregate
Intrinsic Value
Outstanding at June 30, 2020
    11,252,976  $2.81      
Granted
    5,763,300   3.40      
Exercised
    (119,042)   2.22      
Forfeited / Cancelled
    (223,828)   3.65      
   
 
 
         
Outstanding at March 31, 2021
    16,673,406   3.01    7.9   $9,775,096
   
 
 
         
Vested and exercisable at March 31, 2021
    7,802,361   2.74    6.7   $7,006,856
Fair Value of Stock Options Weighted-Average Assumptions Used
The following weighted-average assumptions were used to determine the fair value of options granted during the period:
 
   
Nine Months Ended
March 31,
   
2021
 
2020
Risk-free interest rate
    0.5%   1.8%
Expected life (years)
    6.0   6.0
Expected volatility
    81.1%   73.6%
Dividend yield
    0.0%   0.0%
Weighted-average grant date fair value
   $2.32  $1.60